<VariationArchive RecordType="classified" VariationID="102531" VariationName="NM_000277.3(PAH):c.111dup (p.Ile38fs)" VariationType="Duplication" Accession="VCV000102531" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-04-25" DateCreated="2014-03-19" MostRecentSubmission="2020-01-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="108267" VariationID="102531">
      <GeneList>
        <Gene Symbol="PAH" FullName="phenylalanine hydroxylase" GeneID="5053" HGNC_ID="HGNC:8582" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="102836889" stop="102958441" display_start="102836889" display_stop="102958441" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="103232103" stop="103311380" display_start="103232103" display_stop="103311380" Strand="-" />
          </Location>
          <OMIM>612349</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000277.3(PAH):c.111dup (p.Ile38fs)</Name>
      <CanonicalSPDI>NC_000012.12:102912847:C:CC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="102912847" stop="102912848" display_start="102912847" display_stop="102912848" variantLength="1" positionVCF="102912847" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="103306625" stop="103306626" display_start="103306625" display_stop="103306626" variantLength="1" positionVCF="103306625" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>I38fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.103306626dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.103306626dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.102912848dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.102912848dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008690.2" sequenceAccession="NG_008690" sequenceVersion="2" change="g.50563dup">
            <Expression>NG_008690.2:g.50563dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000277.3" sequenceAccession="NM_000277" sequenceVersion="3" change="c.111dup" MANESelect="true">
            <Expression>NM_000277.3:c.111dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000268.1" sequenceAccession="NP_000268" sequenceVersion="1" change="p.Ile38fs">
            <Expression>NP_000268.1:p.Ile38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354304.2" sequenceAccession="NM_001354304" sequenceVersion="2" change="c.111dup">
            <Expression>NM_001354304.2:c.111dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341233.1" sequenceAccession="NP_001341233" sequenceVersion="1" change="p.Ile38fs">
            <Expression>NP_001341233.1:p.Ile38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA229354" DB="ClinGen" />
        <XRef Type="rs" ID="199475674" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000277.3(PAH):c.111dup (p.Ile38fs) AND not provided" Accession="RCV000088764" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000277.3(PAH):c.111dup (p.Ile38fs) AND Phenylketonuria" Accession="RCV000993603" Version="1">
        <ClassifiedConditionList TraitSetID="159">
          <ClassifiedCondition DB="MedGen" ID="C0031485">Phenylketonuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2019-04-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-04-03" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2014-03-19" MostRecentSubmission="2020-01-20">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16256386</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/b99c1dbd-f61d-48b6-b621-b15e0731824b</URL>
        </Citation>
        <DescriptionHistory Dated="2020-01-19">
          <Description>not provided</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="159" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3795" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Phenylketonurias</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Phenylketonuria</ElementValue>
                <XRef ID="Phenylketonuria/5714" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009861" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oligophrenia phenylpyruvica</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Folling disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PKU</ElementValue>
                <XRef Type="MIM" ID="261600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000505064" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260641" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330994" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505124" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506557" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529346" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507953" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529111" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000560957" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596351" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Phenylalanine hydroxylase (PAH) deficiency results in intolerance to the dietary intake of the essential amino acid phenylalanine and produces a spectrum of disorders. The risk of adverse outcome varies based on the degree of PAH deficiency. Without effective therapy, most individuals with severe PAH deficiency, known as classic PKU, develop profound and irreversible intellectual disability. Affected individuals on an unrestricted diet who have phenylalanine levels above normal but below 1,200 µmol/L (20 mg/dL) are at much lower risk for impaired cognitive development in the absence of treatment.</Attribute>
                <XRef ID="NBK1504" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301677</ID>
                <ID Source="BookShelf">NBK1504</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="USPSTF, 2008">
                <ID Source="pmc">2267416</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21915151</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24385074</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2014">
                <ID Source="pmc">3918542</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Camp et al., 2014">
                <ID Source="PubMed">24667081</ID>
              </Citation>
              <XRef ID="716" DB="Orphanet" />
              <XRef ID="C0031485" DB="MedGen" />
              <XRef ID="MONDO:0009861" DB="MONDO" />
              <XRef Type="MIM" ID="261600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="214809" SubmissionDate="2012-03-30" DateLastUpdated="2014-03-19" DateCreated="2014-03-19">
        <ClinVarSubmissionID localKey="p.I38fsX19" />
        <ClinVarAccession Accession="SCV000119348" DateUpdated="2014-03-19" DateCreated="2014-03-19" Type="SCV" Version="1" SubmitterName="DeBelle Laboratory for Biochemical Genetics, MUHC/MCH RESEARCH INSTITUTE" OrgID="504816" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000277.1:c.111_112insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>PAHDB_MCGILL_2012_1_31</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="2260697" SubmissionDate="2019-10-07" DateLastUpdated="2020-01-20" DateCreated="2020-01-20">
        <ClinVarSubmissionID localKey="b99c1dbd-f61d-48b6-b621-b15e0731824b" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001146694" DateUpdated="2020-01-20" DateCreated="2020-01-20" Type="SCV" Version="1" SubmitterName="ClinGen PAH Variant Curation Expert Panel" OrgID="506558" OrganizationCategory="consortium" OrgAbbreviation="PAH_EP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-03">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16256386</ID>
          </Citation>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/b99c1dbd-f61d-48b6-b621-b15e0731824b</URL>
          </Citation>
          <Comment>The c.112dupG variant in PAH has been previously reported as a single variant (no second mutation detected) in 1 Chinese patient with classic PKU (PMID: 16256386); BH4 deficiency was not excluded (PP4). The variant is a frameshift variant occurring in exon 2 of 13 in the in the canonical transcript of PAH, a gene fulfilling the most recent criteria for LOF being a known disease mechanism (see PMID: 30192042) (PVS1). It is absent from control databases including ethnically matched individuals, including gnomAD/ExAC, 1000 Genomes, and ESP (PM2). In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PVS1, PP4, PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen PAH ACMG Specifications v1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/blqqhvgi/clingen_pah_acmg_specifications_v1.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000277.1(PAH):c.111_112insG</Name>
            <Name>p.Ile38Aspfs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.12:g.102912848dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA716" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6397269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2260697" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA716" MappingRef="Orphanet">
        <MedGen CUI="C0031485" Name="Phenylketonuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="214809" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

